• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tonix Pharm Holdings (NQ: TNXP )

    0.1393 -0.0060 (-4.13%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11,402,640
    Open 0.1479
    Bid (Size) 0.1393 (7)
    Ask (Size) 0.1400 (355)
    Prev. Close 0.1453
    Today's Range 0.1366 - 0.1545
    52wk Range 0.1180 - 22.14
    Shares Outstanding 22,004,159
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Promising Mpox Vaccine Data at World Vaccine Congress
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at BIO-Europe in Stockholm
    Via Investor Brand Network
    Exposures Product Safety

    Performance

    YTD
    -98.96%
    -98.96%
    1 Month
    +2.80%
    +2.80%
    3 Month
    -72.71%
    -72.71%
    6 Month
    -97.46%
    -97.46%
    1 Year
    -99.11%
    -99.11%

    More News

    Read More
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at ThinkEquity Conference
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Mpox Vaccine Research at World Vaccine Congress Europe 2024
    Via Investor Brand Network
    Exposures Product Safety
    (TNXP) - Analyzing Tonix Pharmaceuticals's Short Interest
    Via Benzinga
    Looking Into Tonix Pharmaceuticals's Recent Short Interest
    Via Benzinga
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives First Payment from U.S. Defense Agency to Develop Broad-Spectrum Antiviral Agents
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits New Drug Application to FDA for TNX-102 SL for Fibromyalgia Treatment
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), X-Chem to Collaborate in Development of Broad-Spectrum Antivirals
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence Product Safety
    Why Tonix Pharmaceuticals (TNXP) Stock Is Moving
    Via Benzinga
    AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances
    Via News Direct
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Featured in Post Discussing Nonaddictive Painkillers Designed to Counter Opioid Crisis
    Via Investor Brand Network
    Exposures Product Safety
    The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
    Via ACCESSWIRE
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins Expert Panel at Long COVID, RECOVER TLC Workshop
    Via Investor Brand Network
    Exposures COVID-19 Product Safety
    AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances
    Via News Direct
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    What's Going On With Tonix Pharmaceuticals Stock Friday?
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) Receives New US Patent for Subcutaneous Administration of Zembrace(R) SymTouch(R) to Treat Migraines
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) TNX-801 Positioned as Viable Contender in Global Fight Against Mpox
    Via Investor Brand Network
    Exposures Product Safety
    New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution
    Via ACCESSWIRE
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports TNX-801 Aligns with WHO Preferred TPP for Mpox Vaccines
    Via Investor Brand Network
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data Demonstrating TNX-801’s Single-Dose Immune Protection Against Mpox
    Via Investor Brand Network
    Exposures Product Safety
    What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.